ATE115951T1 - Glycocyamidin-derivate. - Google Patents

Glycocyamidin-derivate.

Info

Publication number
ATE115951T1
ATE115951T1 AT90810073T AT90810073T ATE115951T1 AT E115951 T1 ATE115951 T1 AT E115951T1 AT 90810073 T AT90810073 T AT 90810073T AT 90810073 T AT90810073 T AT 90810073T AT E115951 T1 ATE115951 T1 AT E115951T1
Authority
AT
Austria
Prior art keywords
glycocyamidine
derivatives
alkyl group
hydrogen
chem
Prior art date
Application number
AT90810073T
Other languages
English (en)
Inventor
Ko Nakamura
Kazuhara Ienaga
Original Assignee
Nippon Zoki Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Zoki Pharmaceutical Co filed Critical Nippon Zoki Pharmaceutical Co
Application granted granted Critical
Publication of ATE115951T1 publication Critical patent/ATE115951T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88—Nitrogen atoms, e.g. allantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT90810073T 1989-02-01 1990-01-31 Glycocyamidin-derivate. ATE115951T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2466989 1989-02-01

Publications (1)

Publication Number Publication Date
ATE115951T1 true ATE115951T1 (de) 1995-01-15

Family

ID=12144550

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90810073T ATE115951T1 (de) 1989-02-01 1990-01-31 Glycocyamidin-derivate.

Country Status (7)

Country Link
US (1) US4957936A (de)
EP (1) EP0381628B1 (de)
JP (1) JP2957217B2 (de)
AT (1) ATE115951T1 (de)
DE (1) DE69015220T2 (de)
DK (1) DK0381628T3 (de)
ES (1) ES2066181T3 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW221689B (de) * 1991-08-27 1994-03-11 Otsuka Pharma Co Ltd
US7101902B2 (en) * 2003-11-21 2006-09-05 The United States Of America As Represented By The Secretary Of The Army 2-guanidinylimidazolidinedione compounds and methods of making and using thereof
CN102859357A (zh) 2010-04-27 2013-01-02 希森美康株式会社 肾脏病诊断用标志物及其利用
EP3416645A4 (de) * 2016-02-18 2019-10-16 Merck Sharp & Dohme Corp. Verbindungen zur behandlung von malaria

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE251937C (de) *
US4657922A (en) * 1985-05-24 1987-04-14 Mcneilab, Inc. Anxiolytic 4,5-dihydro-4-oxo-1H-imidazol-2-yl urea derivatives

Also Published As

Publication number Publication date
JP2957217B2 (ja) 1999-10-04
EP0381628A3 (de) 1991-05-02
JPH02288867A (ja) 1990-11-28
EP0381628B1 (de) 1994-12-21
US4957936A (en) 1990-09-18
DE69015220T2 (de) 1995-05-11
DE69015220D1 (de) 1995-02-02
EP0381628A2 (de) 1990-08-08
ES2066181T3 (es) 1995-03-01
DK0381628T3 (da) 1995-05-01

Similar Documents

Publication Publication Date Title
AU515774B2 (en) Benzopyran derivatives
FI965020A (fi) Uusia yhdisteitä, menetelmiä niiden valmistamiseksi ja kasvaintenvastaisia aineita
ES2059893T3 (es) Derivados de difenilurea.
DE3483861D1 (de) Oliglucosidderivate.
ES548357A0 (es) Procedimiento para preparar derivados de n-(adamantil-1)-pirrolidon-5-carboxamida-2.
ES2188481T3 (es) Derivados de polinalbufina.
MX170732B (es) Composicion de derivados de succinimida y su uso
ES2065994T3 (es) Beta-dicetonas substituidas.
DE69015220T2 (de) Glycocyamidin-Derivate.
FI854596A (fi) Nytt foerfarande foer uppdelning av racemiska -naftylpropionsyror i optiska isomerer.
KR960700245A (ko) 메토트렉세이트 유도체[methotrexate derivative]
DK0485204T3 (da) Fremgangsmåde til fremstilling af 3-alkoxymethyl-cephalosporin-derivater
KR900018083A (ko) 에폭시숙신산 유도체
PT971899E (pt) Compostos de hexa-hidroindenopiridina possuindo actividade antiespermatogenica.
ATE217311T1 (de) Cyclopropancyclus enthaltende purinderivate
ATE86629T1 (de) 4-piperidincarboxamid-derivate.
ES2072299T3 (es) Derivados de 3-desoxi-micaminosil-tilonolida.
ATE75468T1 (de) Substituierte 3-aminosydnonimine, verfahren zu ihrer herstellung und ihre verwendung.
DE68926016D1 (de) Halogeno-4-Methylpyrazole und Verfahren zu ihrer Herstellung
DK0455899T3 (da) Prostaglandin I-analog
ES2139670T3 (es) Derivados de 1-fenilpirrolidona con actividad optica y preparacion de los mismos.
KR840001554A (ko) 벤즈아미드 유도체의 제법
ES488385A0 (es) Procedimiento de preparacion de derivados de la xantona
TH13791EX (th) อนุพันธ์ต่างๆของกรดบิวไทริค

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee